Literature DB >> 6120313

Intestinal antibody responses after immunisation with cholera B subunit.

A M Svennerholm, D A Sack, J Holmgren, P K Bardhan.   

Abstract

In about 80% of Bangladeshi volunteers a single oral or intramuscular immunisation with a new cholera toxoid immunogen (B subunit) gave rise to a local intestinal secretory immunoglobulin A (IgA) antitoxin response as measured in intestinal-lavage fluid by enzyme-linked immunosorbent assay methods. The rise in IgA antitoxin titre was similar for both immunisation routes and was comparable to that seen after clinical cholera; however, the response persisted longer after oral than intramuscular immunisation. A second immunisation by either route evoked an antitoxin response which usually closely resembled that seen after the first immunisation.

Mesh:

Substances:

Year:  1982        PMID: 6120313     DOI: 10.1016/s0140-6736(82)91568-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.

Authors:  E L Johansson; L Wassén; J Holmgren; M Jertborn; A Rudin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Appraisal of gut lavage in the study of intestinal humoral immunity.

Authors:  S O'Mahony; J R Barton; S Crichton; A Ferguson
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.

Authors:  B D Forrest
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates.

Authors:  E L Johansson; C Rask; M Fredriksson; K Eriksson; C Czerkinsky; J Holmgren
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.

Authors:  S Migasena; P Pitisuttitham; P Suntharasamai; B Prayurahong; W Supanaranond; V Desakorn; R E Black
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

9.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

10.  Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.

Authors:  Weili Liang; Shixia Wang; Fenggang Yu; Lijuan Zhang; Guoming Qi; Yanqing Liu; Shouyi Gao; Biao Kan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.